🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

28+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 28 recruiting trials for “frontotemporal-dementia

Enrolling by InvitationNCT07239843

Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders

🏥 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau📍 1 site📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT06604520

Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia

👨‍⚕️ Christopher Morrow, MD, Johns Hopkins University📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT06856850

Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches

🏥 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta📍 4 sites📅 Started Feb 2025View details ↗
RecruitingNCT06803784

Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders

👨‍⚕️ TERESA ESPOSITO, PhD, IRCCS INM Neuromed📍 1 site📅 Started Feb 2025View details ↗
Enrolling by InvitationNCT07234851

Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.

🏥 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06668610

A Multifocal TDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia

🏥 University of Campania Luigi Vanvitelli📍 1 site📅 Started Oct 2024View details ↗
EARLY_Phase 1RecruitingNCT06511752

Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia

🏥 University of Texas at Austin📍 1 site📅 Started May 2024View details ↗
RecruitingNCT06528964

Proteinopathies Expression in Skin of Neurodegenerative Disorders

🏥 Universidad Autonoma de San Luis Potosí📍 1 site📅 Started Dec 2023View details ↗
Phase 1, PHASE2RecruitingNCT06064890

A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

🏥 AviadoBio Ltd📍 19 sites📅 Started Aug 2023View details ↗
Enrolling by InvitationNCT05457998

BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers

👨‍⚕️ Edward Huey, MD, Butler Hospital Memory and Aging Program📍 1 site📅 Started Jun 2023View details ↗
Enrolling by InvitationNCT05617014

Alzheimer's Disease Neuroimaging Initiative 4

👨‍⚕️ Michael Weiner, MD, University of California, San Francisco📍 62 sites📅 Started Jun 2023View details ↗
RecruitingNCT05779813

Genetic Frontotemporal Dementia Initiative for Neurodevelopment

👨‍⚕️ Elizabeth Finger, MD, Western University📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05742698

Nabilone for Agitation in Frontotemporal Dementia

🏥 Simon Ducharme, MD📍 7 sites📅 Started Mar 2023View details ↗
RecruitingNCT05642351

Autobiographical Specificity

🏥 Nantes University Hospital📍 1 site📅 Started Feb 2023View details ↗
NARecruitingNCT05326750

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

👨‍⚕️ Eino Solje, MD, PhD, Kuopio University Hospital📍 1 site📅 Started Nov 2022View details ↗
RecruitingNCT05288842

Tanycytes in Alzheimer's Disease and Frontotemporal Dementia

👨‍⚕️ Thibaud LEBOUVIER, MD,PhD, University Hospital, Lille📍 1 site📅 Started Sep 2022View details ↗
RecruitingNCT04865172

ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions

👨‍⚕️ Richard Levy, MD, PhD, Institut National de la Santé Et de la Recherche Médicale, France📍 1 site📅 Started May 2022View details ↗
NAEnrolling by InvitationNCT06826157

The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias

👨‍⚕️ Massimo MF Filippi, MD, IRCCS Ospedale San Raffaele📍 1 site📅 Started Nov 2021View details ↗
Phase 1, PHASE2RecruitingNCT04747431

A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes

👨‍⚕️ Tiffini Voss, MD, PhD, Passage Bio, Inc.📍 10 sites📅 Started Sep 2021View details ↗
Enrolling by InvitationNCT04961450

Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China

🏥 Peking University Third Hospital📍 1 site📅 Started Jun 2021View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →